Innovation

At NanoPoint Innovations, we are exclusively focused on advancing the future of diagnostics with our cutting-edge aptamer-based electrochemical biosensing platform. Our technology is designed to provide precision, accessibility, and real-time health insights, making advanced diagnostics possible not only at point-of-care (POC) facilities but also for at-home use. At the core of our proprietary platform are aptamers—engineered single-stranded DNA or RNA molecules that are meticulously crafted in our lab to bind with unmatched specificity and affinity to a wide array of disease biomarkers. These biomarkers range from proteins and genetic mutations to microRNAs and small molecules associated with conditions such as cancer, infectious diseases, cardiovascular disorders, and metabolic imbalances. When an aptamer binds to its target, it initiates an electrochemical reaction that is specifically designed to be quantifiable, providing fast, accurate, and actionable diagnostic information.

What truly sets our biosensors apart is their unparalleled versatility and ability to quantify biomarkers with exceptional precision. Our devices are exclusively engineered for portability and simplicity, enabling non-invasive sample collection from saliva, urine, or a single drop of blood. This allows our users to detect diseases in their earliest stages from the comfort of their homes. For instance, our sensors can quantify cancer-specific biomarkers, such as circulating tumor DNA or cancer-related proteins, facilitating early detection of diseases like breast, lung, or colorectal cancer. Additionally, our technology can accurately quantify viral or bacterial antigens, offering a rapid diagnostic solution for infectious diseases such as influenza or COVID-19, as well as monitor chronic conditions like diabetes by measuring glucose and metabolic markers. The electrochemical biosensing mechanism is finely tuned to detect even trace amounts of biomarkers, ensuring highly accurate, quantifiable results that are both reliable and suitable for frequent at-home use.

The strength of our technology lies in the sophisticated fusion of advanced materials science, biochemical engineering, and our exclusive focus on electrochemical aptamer detection. By combining these elements, we achieve exceptional sensitivity and specificity while keeping our devices compact, affordable, and scalable. Our sensors are specifically designed to minimize cross-reactivity and interference, ensuring precise and quantifiable results even in complex biological samples. Furthermore, the adaptability of our platform means that new aptamers can be developed rapidly to address emerging diagnostic needs or global health challenges. To elevate the power of our biosensors even further, we are integrating artificial intelligence (AI) to provide real-time data analysis, advanced pattern recognition, and tailored health recommendations. This combination of biosensor technology and AI not only guarantees high-precision diagnostics but also empowers users with predictive insights, enabling proactive health management. At NanoPoint Innovations, we are relentlessly committed to democratizing healthcare by providing advanced, lab-made diagnostics that are accessible, portable, and user-friendly, transforming how individuals and healthcare providers detect, monitor, and manage diseases.